Compound Summary
3-bromo-7-nitroindazole
Compound Information
3-bromo-7-nitroindazole
Compound Name: | 3-bromo-7-nitroindazole |
Compound CID: | 1649 |
Synonyms: | 3-bromo-7-nitroindazole 3-Bromo-7-nitro-1H-indazole 74209-34-0 3-bromo-7-nitro-2H-indazole 3-bromo-7NI More... |
Iupac Name: | 3-bromo-7-nitro-2H-indazole |
InChI: | InChI=1S/C7H4BrN3O2/c8-7-4-2-1-3-5(11(12)13)6(4)9-10-7/h1-3H,(H,9,10) |
InChIKey: | NFSTZPMYAZRZPC-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC2=C(NN=C2C(=C1)[N+](=O)[O-])Br |
Isomeric Smiles: | C1=CC2=C(NN=C2C(=C1)[N+](=O)[O-])Br |
Molecular Weight: | 242.03 |
Molecular Formula: | C7H4BrN3O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
3-bromo-7-nitroindazole
Molecular Weight: | 242.03 |
Molecular Formula: | C7H4BrN3O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 13 |
Complexity: | 220 |
Synonyms
3-bromo-7-nitroindazole
| 3-bromo-7-nitroindazole | 3-bromo-7-nitroindazole |
|---|---|
3-bromo-7-nitroindazole |
3-Bromo-7-nitro-1H-indazole |
74209-34-0 |
3-bromo-7-nitro-2H-indazole |
3-bromo-7NI |
CHEMBL479014 |
MFCD00159910 |
1H-Indazole,3-bromo-7-nitro- |
SR-01000075708 |
Bromo-7-nitroindazole |
Tocris-0735 |
Lopac-B-2050 |
3-Br-7NI |
Lopac0_000161 |
BSPBio_001502 |
BSPBio_002434 |
KBioGR_000222 |
KBioSS_000222 |
SCHEMBL499421 |
SCHEMBL499422 |
SPECTRUM1505105 |
GTPL5113 |
BCBcMAP01_000129 |
KBio2_000222 |
KBio2_002790 |
KBio2_005358 |
KBio3_000443 |
KBio3_000444 |
AMY9474 |
DTXSID90274319 |
3-Bromo-7-nitro-1H-indazole # |
Bio1_000424 |
Bio1_000913 |
Bio1_001402 |
Bio2_000222 |
Bio2_000702 |
HMS1361L04 |
HMS1791L04 |
HMS1989L04 |
HMS3260B03 |
HMS3266N19 |
HMS3402L04 |
HMS3411F05 |
HMS3649K16 |
HMS3675F05 |
ZINC3870920 |
Tox21_500161 |
BDBM50270528 |
HSCI1_000239 |
SBB099519 |
AKOS005070136 |
CCG-204256 |
CS-W020666 |
DB01997 |
LP00161 |
MCULE-1752377285 |
PB13032 |
SB19947 |
SDCCGSBI-0050149.P002 |
VI20026 |
IDI1_033972 |
NCGC00015143-01 |
NCGC00015143-02 |
NCGC00015143-03 |
NCGC00015143-04 |
NCGC00015143-05 |
NCGC00015143-06 |
NCGC00015143-07 |
NCGC00015143-08 |
NCGC00015143-09 |
NCGC00015143-10 |
NCGC00024756-01 |
NCGC00024756-02 |
NCGC00024756-03 |
NCGC00024756-04 |
NCGC00024756-05 |
NCGC00024756-06 |
NCGC00024756-07 |
NCGC00024756-08 |
NCGC00260846-01 |
QC-10364 |
AB0038182 |
HY-101175 |
B6426 |
EU-0100161 |
FT-0615185 |
ST50306995 |
Y5539 |
09B340 |
B 2050 |
Bromo-7-nitroindazole 3-Bromo-7-nitroindazole |
1W-0945 |
3-Bromo-7-nitroindazole, >=98% (TLC), powder |
SR-01000075708-1 |
SR-01000075708-3 |
SR-01000075708-6 |
BRD-K24689407-001-03-0 |
BRD-K24689407-001-04-8 |
BRD-K24689407-001-05-5 |
Q27073725 |
Experimental Data
3-bromo-7-nitroindazole
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -5.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
3-bromo-7-nitroindazole
Statistics Data
3-bromo-7-nitroindazole
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -5.000000000000000 | 1 | 1 |
Statistics Data Visualization
3-bromo-7-nitroindazole
